SCHEMBL30749031

SCHEMBL30749031

CCCCOC(=O)N1CC(=O)C[C@@H]1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
GBA2 Q9HCG7 1/20 0.41
ALDH1A1 P00352 1/20 0.38
BCHE P06276 1/20 0.37
ATM Q13315 1/20 0.36
TSHR P16473 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HPGD P15428 1/20 0.34
NAAA Q02083 2/20 0.33
ECE1 P42892 1/20 0.33
ESR1 P03372 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22117681 0.85 SMN1; SMN2 (0.42) LMNASMN1; SMN2POLBGBA2ALDH1A1
SCHEMBL31612903 0.85 SMN1; SMN2 (0.42) LMNASMN1; SMN2POLBGBA2ALDH1A1
SCHEMBL1835614 0.85 SMN1; SMN2 (0.42) LMNASMN1; SMN2POLBGBA2ALDH1A1
SCHEMBL6017672 0.82 GBA2 (0.39) LMNASMN1; SMN2POLBGBA2ALDH1A1
SCHEMBL31612922 0.81 LMNA (0.43) LMNASMN1; SMN2POLBGBA2ALDH1A1
SCHEMBL13390099 0.81 HTR2C (0.31)
SCHEMBL27844684 0.80 MMP2 (0.46) LMNASMN1; SMN2POLBGBA2ALDH1A1
SCHEMBL14918089 0.80 MMP2 (0.46) LMNASMN1; SMN2POLBGBA2ALDH1A1
SCHEMBL7788793 0.79 GBA2 (0.51) LMNASMN1; SMN2POLBGBA2ALDH1A1
SCHEMBL30118071 0.78 LMNA (0.43) LMNASMN1; SMN2POLBGBA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565588-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF Suzhou Keen Therapeutics Co., Ltd. (CN) 2025-06-11 EP disclosed
WO-2023241620-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) 2023-12-21 WO disclosed